Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/LQDA/vs peers

LQDALiquidia Corpvs its industry peers

A metric-by-metric comparison of Liquidia Corp against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
CompanyMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
LQDALiquidia CorpThis$3.8B#830.1x#319.3x#1123.8x#51031.2%#147.1%#4-32.5%#5-35.3%#11————
DNTHDianthus Therapeutics, Inc. /DE/$4.7B#1—4.0x#62326.4x#10-67.3%#9-91.1%#12-8739.3%#10-13.9%#8——148.7%#2—
TVTXTravere Therapeutics, Inc.$4.6B#2—203.9x#129.4x#3110.5%#392.1%#1-12.8%#4-113.1%#12——38.8%#5—
GOSSGossamer Bio, Inc.$4.4B#3——91.3x#8-57.7%#8-201.4%#13-352.2%#8———-95.3%#9—
GPCRStructure Therapeutics Inc.$4.4B#4—3.2x#4——-15.2%#7—-10.4%#7——-37.1%#8—
EWTXEdgewise Therapeutics, Inc.$4.2B#5—9.3x#9——-25.4%#8—-0.0%#4-50.9%#6—112.7%#4—
ARQTArcutis Biotherapeutics, Inc.$4.1B#6146.6x#418.4x#1010.8x#491.3%#488.5%#2-3.3%#3-7.3%#5-4.1%#3—30.3%#6—
TNGXTango Therapeutics, Inc.$4.0B#7—3.9x#564.5x#748.3%#522.0%#5-178.4%#6-9.9%#6——197.6%#1—
ABCLAbCellera Biologics Inc.$3.8B#9—4.2x#750.0x#6160.6%#210.1%#6-289.0%#7-16.3%#9-28.0%#4—128.6%#3—
XENEXenon Pharmaceuticals Inc.$3.8B#10—3.0x#2500.3x#9—-47.6%#10-4974.3%#9-27.8%#10-32.5%#5—-5.7%#7—
OGN$3.6B#1117.8x#23.0x#30.6x#1-2.9%#7-78.4%#1114.9%#115.7%#24.9%#25#1—2.4%#1
ACAD$3.6B#129.3x#12.7x#13.3x#211.9%#673.0%#39.8%#229.9%#111.4%#1———
DYN$3.4B#13—4.8x#8——-40.6%#9—-0.0%#3-1301.5%#7———

Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

LQDA's peers

DNTHTVTXGOSSGPCREWTXARQTTNGXABCLXENEOGNACADDYN
← LQDA overview